1. Home
  2. EVO vs SHO Comparison

EVO vs SHO Comparison

Compare EVO & SHO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • EVO
  • SHO
  • Stock Information
  • Founded
  • EVO 1993
  • SHO 1995
  • Country
  • EVO Germany
  • SHO United States
  • Employees
  • EVO N/A
  • SHO N/A
  • Industry
  • EVO Biotechnology: Pharmaceutical Preparations
  • SHO Hotels/Resorts
  • Sector
  • EVO Health Care
  • SHO Consumer Discretionary
  • Exchange
  • EVO Nasdaq
  • SHO Nasdaq
  • Market Cap
  • EVO 1.4B
  • SHO 1.7B
  • IPO Year
  • EVO 2021
  • SHO 1995
  • Fundamental
  • Price
  • EVO $3.76
  • SHO $8.69
  • Analyst Decision
  • EVO Buy
  • SHO Hold
  • Analyst Count
  • EVO 2
  • SHO 6
  • Target Price
  • EVO $5.90
  • SHO $10.00
  • AVG Volume (30 Days)
  • EVO 159.9K
  • SHO 2.5M
  • Earning Date
  • EVO 08-13-2025
  • SHO 08-06-2025
  • Dividend Yield
  • EVO N/A
  • SHO 4.13%
  • EPS Growth
  • EVO N/A
  • SHO N/A
  • EPS
  • EVO N/A
  • SHO 0.10
  • Revenue
  • EVO $851,944,444.00
  • SHO $922,708,000.00
  • Revenue This Year
  • EVO $10.08
  • SHO $7.98
  • Revenue Next Year
  • EVO $10.99
  • SHO $3.67
  • P/E Ratio
  • EVO N/A
  • SHO $88.84
  • Revenue Growth
  • EVO 1.50
  • SHO N/A
  • 52 Week Low
  • EVO $2.84
  • SHO $7.45
  • 52 Week High
  • EVO $5.64
  • SHO $12.41
  • Technical
  • Relative Strength Index (RSI)
  • EVO 41.37
  • SHO 47.27
  • Support Level
  • EVO $4.06
  • SHO $8.43
  • Resistance Level
  • EVO $4.44
  • SHO $8.90
  • Average True Range (ATR)
  • EVO 0.11
  • SHO 0.25
  • MACD
  • EVO -0.04
  • SHO -0.03
  • Stochastic Oscillator
  • EVO 0.00
  • SHO 28.57

About EVO Evotec SE

Evotec is a drug discovery partnership firm providing solutions to pharmaceutical and biotechnology companies, academic institutions, foundations, and nonprofit organizations. The company offers services in a variety of therapeutic areas, including central nervous system disorders, diabetes, inflammation, oncology, infectious diseases, and women's health. The shared R&D segment, roughly 80% of sales, provides drug discovery and manufacturing services on a typical fee-for-service basis and integrated drug discovery collaborations based on its proprietary, internally developed assets. The Just-Evotec Biologics segment, about 20% of sales, offers CDMO services for biologics. As of 2023, the company has over 5,000 employees and 18 production sites mainly in Europe and the United States.

About SHO Sunstone Hotel Investors Inc. Sunstone Hotel Investors Inc.

Sunstone Hotel Investors Inc is a real estate investment trust that acquires, owns, manages, and renovates the full-service hotel and select-service hotel properties across various states in the United States. Its firm's portfolio consists upper upscale and luxury hotels located in convention, resort destination and urban markets. Its majority of the hotels operate under a brand owned by Marriott, Hilton, Hyatt, Four Seasons or Montage. It operates geographically in Califiornia which generates the majority of its revenue; Florida; and Hawaii. The company's sole source of income is hotel revenue from its hotel ownership segment.

Share on Social Networks: